1 min read

ID: 68

Discovery Date: 07 May 2021, 11:43:30 UTC

Published Date: 2021-05-07 16:00:00

Source: Clinical Trials.gov

Link: https://clinicaltrials.gov/ct2/show/NCT04878211?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14

Abstract

Condition:   Relapsing Multiple Sclerosis (RMS)
Interventions:   Drug: Ofatumumab;   Biological: mRNA COVID-19 vaccine;   Drug: interferon or glatiramer acetate
Sponsor:   Novartis Pharmaceuticals
Not yet recruiting

Noun Phrases in Title

This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.